Stay updated on Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.

Latest updates to the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page
- Check2 days agoChange DetectedAn NIH site-wide notice announces a transition from using “Artificial Intelligence” to “Super Intelligence” terminology under an executive order.SummaryDifference0.8%

- Check9 days agoChange DetectedThe site’s displayed software revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check16 days agoChange DetectedThe footer site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry for v3.7.0 was added to the study record history, and the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study’s record history now shows a new revision entry (v3.6.6) and removes the previous revision (v3.6.5), updating the version history.SummaryDifference0.1%

- Check79 days agoChange DetectedA new page revision (v3.6.5) was added to the study record history. The previous revision (v3.6.4) was removed, reflecting an update to the page's versioning metadata rather than study content.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib with Letrozole in HER2+ ER+ MBC Clinical Trial page.